.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
McKinsey
Accenture
Dow
Cerilliant
Merck
US Army
Fuji
Novartis
Farmers Insurance

Generated: June 27, 2017

DrugPatentWatch Database Preview

CARTIA XT Drug Profile

« Back to Dashboard

What is the patent landscape for Cartia Xt, and when can generic versions of Cartia Xt launch?

Cartia Xt is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.

The generic ingredient in CARTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

Summary for Tradename: CARTIA XT

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list82
Patent Applications: see list2,093
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARTIA XT at DailyMed

Pharmacology for Tradename: CARTIA XT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
CARTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL074752-002Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
CARTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL074752-004Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
CARTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL074752-001Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
CARTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL074752-003Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Dow
Accenture
UBS
Novartis
Citi
Merck
Cerilliant
Boehringer Ingelheim
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot